Women with von Willebrand disease (VWD) in the U.S. are 70% more likely to experience heavy bleeding after childbirth, known as postpartum hemorrhage, than…
News
Even though immune thrombocytopenia (ITP) is a bleeding disorder, people with the disease can paradoxically experience thrombosis — abnormal clots that block blood flow,…
The results of a full blood count test — called a CBC, or complete blood count, by clinicians — may help distinguish people with…
The approved injection therapy Nplate (romiplostim) is well tolerated and effective for both adults and children with immune thrombocytopenia (ITP), according to…
A multimodal treatment approach that included off-label emicizumab, a drug approved for hemophilia A, stopped severe, hard-to-treat gastrointestinal bleeding in a 72-year-old woman with acquired…
September is National ITP Awareness Month in the U.S., a time when advocates work to raise awareness and support research into immune thrombocytopenia (ITP).
HMB-002, an experimental antibody-based treatment from Hemab Therapeutics for von Willebrand disease (VWD), increased levels of von Willebrand factor (VWF) and improved measures…
Immune thrombocytopenia (ITP) can occur in people with antiphospholipid syndrome (APS), another immune disorder — and people who have co-occurring ITP and APS almost…
An Iranian woman with congenital thrombotic thrombocytopenic purpura (TTP) successfully delivered a healthy baby boy after receiving regular infusions of fresh frozen plasma and…
Many people with von Willebrand disease (VWD) may experience bleeding for years before being diagnosed, and some cases may still go unrecognized, according to…
